A similar scenario with a different outcome involves subject Clin6 who was referred for EpiSign analysis as a result of negative molecular sequencing (CHD7 and SEMA3E), negative microarray, and negative exome analysis with the phenotype strongly suggestive of CHARGE syndrome. The gene discussed is SEMA3E; the disease is CHARGE syndrome.